Decidual NK cells regulate key developmental processes at the human fetal-maternal interface

Nature Medicine

Volumn 12, Issue 9, 2006, Pages 1065-1074

  Hanna, Jacob ^a   Goldman Wohl, Debra ^b   Hamani, Yaron ^b   Avraham, Inbal ^c   Greenfield, Caryn ^b   Natanson Yaron, Shira ^b   Prus, Diana ^b   Cohen Daniel, Leonor ^a   Arnon, Tal I ^a   Manaster, Irit ^a   Gazit, Roi ^a   Yutkin, Vladimir ^b   Benharroch, Daniel ^d   Porgador, Angel ^d   Keshet, Eli ^c   Yagel, Simcha ^b   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8;

ARTICLE; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXICITY; DEVELOPMENTAL BIOLOGY; FETUS CELL; FETUS MEMBRANE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOLOGY; INNATE IMMUNITY; MATERNAL PLASMA; MICROARRAY ANALYSIS; NATURAL KILLER CELL; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLAST;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTIGENS, CD; ANTIGENS, CD56; DECIDUA; FEMALE; FETUS; HUMANS; INTERLEUKIN-8; KILLER CELLS, NATURAL; MATERNAL-FETAL EXCHANGE; MEMBRANE GLYCOPROTEINS; MICE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; PREGNANCY; RECEPTORS, CHEMOKINE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, KIR; TROPHOBLASTS;

EID: 33748440547     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1452     Document Type: Article

References (49)

1. Red-Horse, K. et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J. Clin. Invest. 114, 744-754 (2004).
2. Zhou, Y. et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J. Clin. Invest. 99, 2139-2151 (1997).
3. Zhou, Y., Genbacev, O., Damsky, C.H. & Fisher, S.J. Oxygen regulates human cytotrophoblast differentiation and invasion: implications for endovascular invasion in normal pregnancy and in pre-eclampsia. J. Reprod. Immunol. 39, 197-213 (1998).
4. Fisher, S.J. The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod. Biol. Endocrinol. 2, 53 (2004).
5. Hanna, J. et al. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells. Blood 102, 1569-1577 (2003).
6. Drake, P.M. et al. Human placental cytotrophoblasts attract monocytes and CD56(bright) natural killer cells via the actions of monocyte inflammatory protein 1alpha. J. Exp. Med. 193, 1199-1212 (2001).
7. King, A. et al. Functions of human decidual NK cells. Am. J. Reprod. Immunol. 35, 258-260 (1996).
8. Koopman, L.A. et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198, 1201-1212 (2003).
9. Cooper, M.A., Fehniger, T.A. & Caligiuri, M.A. The biology of human natural killer-cell subsets. Trends Immunol. 22, 633-640 (2001).
10. Hanna, J. et al. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J. Immunol. 173, 6547-6563 (2004).
11. Bulmer, J.N. & Lash, G.E. Human uterine natural killer cells: a reappraisal. Mol. Immunol. 42, 511-521 (2005).
12. Tabiasco, J. et al. Human decidual NK cells: unique phenotype and functional properties - a review. Placenta 27 (Suppl. 1), 34-39 (2006).
13. Hanna, J. et al. Novel APC-like properties of human NK cells directly regulate T cell activation. J. Clin. Invest. 114, 1612-1623 (2004).
14. Leonard, S. et al. Mechanisms regulating immune cell contributions to spiral artery modification - facts and hypotheses - a review. Placenta 27 (Suppl. 1), 40-46 (2006).
15. Monk, J.M., Leonard, S., McBey, B.A. & Croy, B.A. Induction of murine spiral artery modification by recombinant human interferon-gamma. Placenta 26, 835-838 (2005).
16. Ashkar, A.A. & Croy, B.A. Functions of uterine natural killer cells are mediated by interferon gamma production during murine pregnancy. Semin. Immunol. 13, 235-241 (2001).
17. Ashkar, A.A., Di Santo, J.P. & Croy, B.A. Interferon γ contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 192, 259-270 (2000).
18. Guimond, M.J. et al. Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in TgE26 mice. Biol. Reprod. 56, 169-179 (1997).
19. Moffett, A. & Loke, Y.W. The immunological paradox of pregnancy: a reappraisal. Placenta 25, 1-8 (2004).
20. Hiby, S.E. et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200, 957-965 (2004).
21. Langer, N., Beach, D. & Lindenbaum, E.S. Novel hyperactive mitogen to endothelial cells: human decidual NKG5. Am. J. Reprod. Immunol. 42, 263-272 (1999).
22. Tjwa, M., Luttun, A., Autiero, M. & Carmeliet, P. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis. Cell Tissue Res. 314, 5-14 (2003).
23. Goldman-Wohl, D.S., Ariel, I., Greenfield, C., Hanoch, J. & Yagel, S. HLA-G expression in extravillous trophoblasts is an intrinsic property of cell differentiation: a lesson learned from ectopic pregnancies. Mol. Hum. Reprod. 6, 535-540 (2000).
24. McMaster, M.T. et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J. Immunol. 154, 3771-3778 (1995).
25. Corthay, A. et al. Primary antitumor immune response mediated by CD4+ T cells. Immunity 22, 371-383 (2005).
26. Zhang, L. et al. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res. 60, 3655-3661 (2000).
27. Katz, G. et al. MHC class I-independent recognition of NK-activating receptor KIR2DS4. J. Immunol. 173, 1819-1825 (2004).
28. Katz, G., Markel, G., Mizrahi, S., Arnon, T.I. & Mandelboim, O. Recognition of HLACw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4. J. Immunol. 166, 7260-7267 (2001).
29. Gonen-Gross, T. et al. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J. Immunol. 171, 1343-1351 (2003).
30. Shiroishi, M. et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 100, 8856-8861 (2003).
31. Moretta, A., Bottino, C., Mingari, M.C., Biassoni, R. & Moretta, L. What is a natural killer cell? Nat. Immunol. 3, 6-8 (2002).
32. Lanier, L.L. NKG2D in innate and adaptive immunity. Adv. Exp. Med. Biol. 560, 51-56 (2005).
33. Arnon, T.I. et al. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31, 2680-2689 (2001).
34. Mandelboim, O. et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409, 1055-1060 (2001).
35. Arnon, T.I. et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 6, 515-523 (2005).
36. Kopcow, H.D. et al. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc. Natl. Acad. Sci. USA 102, 15563-15568 (2005).
37. Parham, P. NK cells and trophoblasts: partners in pregnancy. J. Exp. Med. 200, 951-955 (2004).
38. Li, X.F. et al. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J. Clin. Endocrinol. Metab. 86, 1823-1834 (2001).
39. Trundley, A. & Moffett, A. Human uterine leukocytes and pregnancy. Tissue Antigens 63, 1-12 (2004).
40. Tayade, C., Black, G.P., Fang, Y. & Croy, B.A. Differential gene expression in endometrium, endometrial lymphocytes, and trophoblasts during successful and abortive embryo implantation. J. Immunol. 176, 148-156 (2006).
41. Henderson, T.A., Saunders, P.T., Moffett-King, A., Groome, N.P. & Critchley, H.O. Steroid receptor expression in uterine natural killer cells. J. Clin. Endocrinol. Metab. 88, 440-449 (2003).
42. Parham, P. Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response. Immunol. Lett. 92, 11-13 (2004).
43. Coudert, J.D. et al. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood 106, 1711-1717 (2005).
44. Pazmany, L. et al. Human leucocyte antigen-G and its recognition by natural killer cells. J. Reprod. Immunol. 43, 127-137 (1999).
45. Kitaya, K. et al. IL-15 expression at human endometrium and decidua. Biol. Reprod. 63, 683-687 (2000).
46. Verma, S., Hiby, S.E., Loke, Y.W. & King, A. Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol. Reprod. 62, 959-968 (2000).
47. Faust, Z., Laskarin, G., Rukavina, D. & Szekeres-Bartho, J. Progesterone-induced blocking factor inhibits degranulation of natural killer cells. Am. J. Reprod. Immunol. 42, 71-75 (1999).
48. Fehniger, T.A. et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101, 3052-3057 (2003).
49. Rajagopalan, S. et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 4, e9 (2006).